ARTICLE | Clinical News
Prosaptide: Development discontinued
March 14, 2005 8:00 AM UTC
An independent data safety monitoring committee recommended termination of a double-blind, placebo-controlled, dose-ranging, U.S. Phase II trial of Prosaptide to treat peripheral neuropathic pain in 2...